IP Library Granted Patent US 9,696,293
Granted Patent B2
US 9,696,293 · App. 15/003,272 · Granted Jul 4, 2017

Apparatus, method, system for the determination of the aggregation rate of red blood cells

Inventors: Peter Sacchetti (Attleboro, MA); Francesco Frappa (Udine, IT)
Assignee: Alcor Scientific, Inc.
G01N33/4905G01N15/05G01N21/51G01N33/4915G01N2015/0073G01N2015/0092
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,696,293
App. No.
15/003,272
Granted
Jul 4, 2017
Kind
B2
Abstract

Systems and methods for the determination of the aggregation rate of red blood cells. More specifically, the subject technology is used to determine the aggregation rate of red blood cells, and other parameters related to these, such as viscosity, deformability, elasticity, density, in the field of in vitro medical analyses, using optical systems after or during vibration for red blood cell disruption and redistribution. Once the detected light variation stops decreasing (e.g., a minimum is reached), complete disruption is accomplished for evaluation of the blood sample.

Claims (45)

1. An apparatus for determining the aggregation rate of red blood cells, comprising:

(a) an optical receiver positioned to detect light from a blood sample portion comprising red blood cells that have aggregated;

(b) a main controller coupled to the optical receiver for recording an aggregation rate of the red blood cells of the blood sample portion for a predetermined time based upon detected light variation;

(c) a hydraulic circuit for providing the blood sample portion;

(d) a reading cell container connected to the hydraulic circuit for receiving the blood sample portion; and

(e) a light emitter source to pass light into the blood sample portion.

2. The apparatus of claim 1 , further comprising:

a disruption mechanism connected to the reading cell container for disruption of the red blood cells within the blood sample portion to assist in recording the disruption rate, wherein the main controller activates the disruption mechanism for the disruption of the red blood cells within the blood sample portion until light detected indicates the disruption of aggregate within the blood sample portion.

3. The apparatus of claim 1 , further comprising:

a fluid reservoir connected to the reading cell container for receipt of an evacuated blood sample portion from the reading cell container.

4. The apparatus of claim 1 , wherein the apparatus comprises an evacuation mechanism to evacuate the evacuated blood sample portion from the reading cell container, wherein the evacuation mechanism is configured to provide ultrasound stress to the reading cell container.

5. The apparatus of claim 1 , wherein the reading cell container is configured for the optical detection of aggregation reaction.

6. The apparatus of claim 1 , wherein the apparatus determines a disruption index of the red blood cells as rheological parameters usable for pathologic detection purposes.

7. The apparatus of claim 1 , wherein the apparatus determines a mean red blood cells shape recovery ability.

8. The apparatus of claim 1 , wherein the apparatus determines the plasma viscosity.

9. An apparatus for determining an aggregation rate of red blood cells comprising:

(I) a reading cell container configured to receive a blood sample portion comprising aggregated red blood cells;

(II) an optical receiver positioned to detect light from the blood sample portion while the blood sample portion is in the reading cell container;

(III) a disruption mechanism connected to the reading cell container to disrupt the aggregated red blood cells within the blood sample portion while the blood sample portion is in the reading cell container; and

(IV) a main controller configured to record an aggregation rate of the red blood cells of the blood sample portion based upon detected light variation,

wherein the detected light includes first light that is backscattered.

10. The apparatus of claim 9 , further comprising:

(V) a hydraulic circuit for transporting a blood sample portion comprising red blood cells; and

(VI) a light emitter source to pass light through the blood sample portion while the blood sample portion is in the reading cell container.

11. An apparatus for determining an aggregation rate of red blood cells comprising:

(I) a reading cell container configured to receive a blood sample portion comprising aggregated red blood cells:

(II) an optical receiver positioned to detect light from the blood sample portion while the blood sample portion is in the reading cell container;

(III) a disruption mechanism connected to the reading cell container to disrupt the aggregated red blood cells within the blood sample portion while the blood sample portion is in the reading cell container; and

(IV) a main controller configured to record an aggregation rate of the red blood cells of the blood sample portion based upon detected light variation;

(V) a fluid reservoir; and

(VI) an evacuation mechanism connecting the fluid reservoir to the reading cell container to remove an evacuated blood sample portion from the reading cell container and deposit it within the fluid reservoir, wherein the evacuation mechanism is configured to provide ultrasound stress to the reading cell container.

12. The apparatus of claim 11 , wherein the main controller determines the aggregation rate based upon for a predetermined time of disruption.

13. The apparatus of claim 11 , wherein the main controller determines the aggregation rate based upon data collected from a start of disruption until light detected stops decreasing.

14. The apparatus of claim 11 , wherein the detected light passes through the blood sample and is attenuated.

15. The apparatus of claim 9 , wherein the detected light includes second light that has passed through the blood sample.

16. A method of measuring the disruption rate and the aggregation rate of a sample of red blood cells, the method comprising the steps of:

a) obtaining a blood sample portion comprising aggregated red blood cells;

b) delivering the blood sample portion into the reading cell container of the apparatus of claim 1 ;

c) using the disruption mechanism to disrupt the red blood cell aggregates in the blood sample portion within the reading cell container to distribute and re-suspend the red blood cells;

d) passing light from the light emitter source into the blood sample portion within the reading cell container;

e) receiving and detecting light emitted from the reading cell container at an optical receiver;

f) recording, at a main controller, a disruption rate of the red blood cell aggregates within the blood sample portion based upon the light variation; and

g) recording an aggregation rate of the blood sample portion for a predetermined time based upon detected light variation.

17. The method of claim 16 , wherein the step of using the disruption mechanism includes applying an optimum emulsification power level of electricity to a piezoceramic material determined by initially ramping up electricity applied to the piezoceramic material to a level where cell emulsification of a test sample is detected through the reading cell by the optical receiver.

18. The method of claim 16 , further comprising the step of continuing the disruption of the blood sample portion within the reading cell until the variation in light detected indicates the disruption of the red blood cell aggregates within the blood sample portion.

Assignments (3)
CHANGE OF NAME Recorded Feb 20, 2024
From: ALCOR SCIENTIFIC, INC
To: ALCOR SCIENTIFIC, LLC
Reel/Frame 066626/0978 →
SECURITY INTEREST Recorded Jan 31, 2022
From: AQUARIUS INTERMEDIATE LLC; ALCOR SCIENTIFIC LLC
To: ANTARES CAPITAL LP, AS COLLATERAL AGENT
Reel/Frame 058825/0560 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2017
From: SACCHETTI, PETER J; FRAPPA, FRANCESCO
To: ALCOR SCIENTIFIC, INC.
Reel/Frame 041238/0001 →
Continuity (2)
Continuation 14176307 · Feb 10, 2014
Related Publication 20160252491A1 · Sep 1, 2016